4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Vaishali Pharma Limited (VAISHALI) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India. Its market capitalization is roughly ₹1 billion. In the fiscal year ended 2026-03-31, VAISHALI reported ₹1.0B in revenue and ₹40M in net income.
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹1.0B | ₹979M | ₹818M | ₹638M | — |
| Gross Profit | ₹96M | ₹122M | ₹74M | ₹92M | — |
| Operating Income (EBIT) | ₹56M | ₹59M | ₹63M | ₹90M | — |
| Net Income | ₹40M | ₹8M | ₹7M | ₹66M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-03-31 | 2024-12-31 |
|---|---|---|
| Total Revenue | ₹311M | ₹279M |
| Gross Profit | ₹5M | ₹42M |
| Operating Income (EBIT) | ₹1M | ₹12M |
| Net Income | (₹43M) | ₹14M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹1.2B | ₹1.1B | ₹800M | ₹789M | — |
| Total Liabilities | ₹543M | ₹449M | ₹371M | ₹384M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VAISHALI viewer.
About TickerBase · Data methodology & sources · Privacy · Terms